The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

G•••••• B••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor S• C•••••• P••••••• carried
Principal held
at least $67.1M
sum of BDC pieces, a lower bound
Fair value
$67.1M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Apr 1, 2029
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Mar 31, 2026
Events
3
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Mar 31, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Mar 31, 2026
at least $67.1M100cS+245 bpApr 1, 20291
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, A•••• 2029, P•••• + 2.45%, F•••• rate 9.45%, 6.45% E••• Fee
$67.1M$67.1M
100c
S+245 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Mar 31, 20261$67.1M$67.1M100c0
Dec 31, 20251$67.1M$66.7M100c0
Sep 30, 20251$66.9M$66.2M100c1
What changed
Every change including routine ones
Identity
Group key
G•••••• B•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it